-
【Wednesday Literature Reading】Professor Jia Yujiao| Big Coffee Commentary: Perfection, from the 2022 BSH acute myeloid leukemia laboratory testing practice recommendations to see the latest progress
Time of Update: 2023-01-05
The diagnosis of AML involves combining the patient's clinical presentation with laboratory tests such as morphology, immunology, cytogenetics, and molecular biology assessment (MICM) of peripheral blood and bone marrow cells.
-
[BLOOD] del(1p32) is a poor prognosis for NDMM, and biallele censoring is ultra-risky
Time of Update: 2023-01-04
of France analyzed the data of 2551 NDMM patients in the French Myeloma Collaboration Group (IFM), confirming the adverse effects of del(1p32) in MM, and the copy number of del(1p32) is also important.
-
Guangxi Guigang City built the first new energy electric vehicle
Time of Update: 2022-11-20
According to reports, Guigang City fully relies on transportation and location advantages, and has introduced multiple preferential policies, actively introduced and vigorously supported the development of new energy electric vehicle enterprises to settle in the park, and focused on building a China-ASEAN new energy electric vehicle production base.
-
Issue 14/2014 - Direct and efficient conversion of hydrogen sulfide from natural gas to sulfur
Time of Update: 2022-11-13
(Yan Xu) Convert hydrogen sulfide from natural gas directly and efficiently to sulfurA series modular plant of low submersible sulfur series suitable for the test production of single well and associated gas of sulfur containing natural gas has been successfully promoted and put into production by Sinopec.
-
Issue 3, 2014 - The first set of ethylene waste alkali plant with oxidation technology in China was put into operation
Time of Update: 2022-11-12
(Wu Peng) Recently, the first set of ethylene waste alkali treatment equipment of total biological oxidation technology in China - Lanzhou Petrochemical Company annual 128,000 tons of total biological oxidation technology ethylene waste alkali treatment plant was put into trial operation for 10 days, and the operation is good.
-
Scientists have discovered a unique breast cancer cell that controls the ability to proliferate and colonize the lungs
Time of Update: 2022-10-01
According to a study published in Cell Report in September, scientists from the Tisch Cancer Institute have discovered a mechanism by which certain breast cancer cells regulate their own metastasis, spread from the original tumor site, and decide to invade distant organs, such as the lungs.
-
Gao Xin's team at Suzhou Medical Institute proposed a new method to predict the efficacy of neoadjuvant chemotherapy for advanced gastric cancer
Time of Update: 2022-09-20
In the early stage, gao Xin's team from the Suzhou Institute of Medical Engineering of the Chinese Academy of Sciences and the Shanxi Provincial Cancer Hospital proposed for the first time a method for predicting the efficacy of neoadjuvant chemotherapy for advanced gastric cancer based on artificial intelligence (the relevant results were published in Lancet's EClinicalMedicine, 2022, 101348).
-
Agilyx and TechnipFMC partner to recycle polystyrene
Time of Update: 2022-08-23
A few days ago, Agilyx and TechnipFMC said that the two sides will cooperate to develop a new process for the production of styrene from recycled polystyrene (PS) products, aiming to promote the circular economy .
-
Express treatment of HER2-positive breast cancer, blockbuster ADC has made positive progress
Time of Update: 2022-08-19
▎Edited by WuXi AppTec Content TeamReferences: [1] ENHERTU® Significantly Delayed Disease Progression in DESTINYBreast02 Phase 3 Trial Versus Physician's Choice of Treatment in Patients with HER2 Positive Metastatic Breast Cancer.
-
Interpretation of the 2022 Guidelines for Prostate Cancer Screening, Early Diagnosis and Treatment in China (Part 2
Time of Update: 2022-06-19
Regarding other screening methods, the "Clinical Application of Prostate-Specific Antigen Detection for Prostate Cancer" issued by the National Health and Family Planning Commission in 2015 pointed out that when the serum PSA concentration is ≥4.
-
New technology can save 90% of the curing time of composite materials
Time of Update: 2022-06-16
? OAS's patented Onto chemistry platform provides a series of universal and reliable chemical surface treatments that can be used to improve the adhesion of paints, coatings and adhesives to composite materials and engineering plastics .
-
Li Zhenfei/Wu Denglong/Huang Shengsong's team identified a new target for advanced prostate cancer treatment Cell Press Dialogue with Scientists
Time of Update: 2022-06-06
Finally, the researchers demonstrated through different clinical trials that the metabolic enzyme 3βHSD1 is a more suitable therapeutic target for advanced prostate cancer in the Chinese population; its inhibitors can prevent disease progression in abiraterone-resistant patients .
-
O drug terminated two clinical trials, GSK and Merck parted ways, Gilead's $5 billion cooperation too failed
Time of Update: 2022-04-30
Although this kind of external cooperation can quickly supplement its own pipelines, the projects that big pharmaceutical companies have invested in huge capitals of hundreds of millions of dollars or even billions of dollars in the early stage are faced with the failure of clinical trials, changes in the market competition pattern, and adjustment of the focus of project research and development.
-
Another frontier progress in cellular immunotherapy: the first CAR-Treg therapy has been administered to patients Yimaimeng broke the news
Time of Update: 2022-04-28
TX200 is the company's wholly-owned autologous chimeric antigen receptor-regulated T cell (CAR-Treg) cell therapy candidate for the prevention of immune rejection following HLA-A2-mismatched living-donor kidney transplantation .
-
Technology is advancing rapidly, and the pharmaceutical industry is pushing for intelligent transformation
Time of Update: 2022-04-15
According to reports, in 2021, at the same time as the secondary research and development of varieties, Benxi Sanyao will invest 40 million yuan to carry out intelligent transformation in the production field .
